Brassicaceae: Nutrient analysis and investigation of tolerability in people with Crohn's disease in a New Zealand study

Functional Foods in Health and Disease

Volumn 2, Issue 11, 2012, Pages 460-486

  Campbell, Bobbi ^a   Han, Dug Yeo ^a   Triggs, Christopher M ^a   Fraser, Alan G ^a   Ferguson, Lynnette R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Brassicaceae: Key nutrients: Tolerability: Crohn's Disease

Indexed keywords

EID: 85092677600     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v2i11.70     Document Type: Article

References (106)

1. Porter RS, Kaplan JL, Homeier BP. The Merck manual of patient symptoms: a concise, practical guide to etiology, evaluation, and treatment. Whitehouse Station, NJ: Merck Research Laboratories; 2008.
2. Triggs CM, Munday K, Hu R, Fraser AG, Gearry RB, Barclay ML, Ferguson LR: Dietary factors in chronic inflammation: food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutation Research. 2010, 690(1-2):123-138.
3. Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I: Genes, diet and inflammatory bowel disease. Mutat Res. 2007, 622(1-2):70-83.
4. Ferreira P, Cravo M, Guerreiro CS, Tavares L, Santos PM, Brito M: Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity. Clinical nutrition. 2010, 29(6):819-823.
5. Heaton KW, Thornton JR, Emmett PM: Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. British medical journal. 1979, 2(6193):764-766.
6. Gibson PR, Shepherd SJ: Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. Journal of gastroenterology and hepatology. 2010, 25(2):252-258.
7. 5+ a Day NZ. Fresh Fruit and Vegetables2011; www.5aday.co.nz July 2011-2011.
8. Snowdon R, Luhs W, Friedt W. Oilseed rape. In: Kole C, editor. Genome Mapping and Molecular Breeding in Plants: Oilseeds. New York: Springer; 2007. p. 55-114; 112.
9. Clarke DB: Glucosinolates, structures and analysis in food. AnalMethods. 2010, 2(4):310-325.
10. Bjorkman M, Klingen I, Birch AN, Bones AM, Bruce TJ, Johansen TJ, Meadow R, Molmann J, Seljasen R, Smart LE, Stewart D: Phytochemicals of Brassicaceae in plant protection and human health-influences of climate, environment and agronomic practice. Phytochemistry. 2011, 72(7):538-556.
11. Ballegaard M, Bjergstrom A, Brondum S, Hylander E, Jensen L, Ladefoged K: Self-reported food intolerance in chronic inflammatory bowel disease. Scandinavian journal of gastroenterology. 1997, 32(6):569-571.
12. Hartman C, Eliakim R, Shamir R: Nutritional status and nutritional therapy in inflammatory bowel diseases. World Journal of Gastroenterology. 2009, 15(21):2570-2578.
13. Navarro SL, Li F, Lampe JW: Mechanisms of action of isothiocyanates in cancer chemoprevention: an update. Food & function. 2011, 2(10):579-587.
14. Ministry of Health N Z, New Zealand Institute for Plant Food Research: The Concise NZ Food Composition Tables. 2009.
15. USDA. Phytochemical Database2011; http//www.p1.barc.usda.gov/usda_chem/achem_home.cfm(Journal, Electronic):October 2011, Usda National Nutrient Database for Standard Reference. USDA government; 2011.
16. Neveu V, Perez-Jimenez J, Vos F, Crespy V, Du Chaffaut L, Mennen L, Knox C, Eisner R, Cruz J, Wishart D, Scalbert A: Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database: the journal of biological databases and curation. 2010, 2010.
17. Mcnaughton SA, Marks GC: Development of a food composition database for the estimation of dietary intakes of glucosinolates, the biologically active constituents of cruciferous vegetables. British Journal of Nutrition. 2003, 90(3):687-697.
18. Muir JG, Shepherd SJ, Rosella O, Rose R, Barrett JS, Gibson PR: Fructan and Free Fructose Content of Common Australian Vegetables and Fruit. Agriculture and Food Chemistry. 2007, 55:6619-6627.
19. Joachim G: Responses of people with inflammatory bowel disease to foods consumed. Gastroenterol Nurs. 2000, 23(4):160-167.
20. Ferguson LR, Han DY, Fraser AG, Claudia H, Wen JL, Angharad RM, He D, Nishi K: Genetic factors in chronic inflammation, Single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disesase in New Zealand population. Mutation Research. 2010, 690:108-115.
21. Satsangi J, Silverberg MS, Vermeire S, Colombel JF: The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006, 55(6):749-753.
22. Computing RFFS. R: A language and environment for statistical computing. Vienna, Austria. Cary, NC, USA.: R Foundation for Statistical Computing; 2012.
23. Jones RB, Faragher JD, Winkler SA: Review of the Influence of postharvest treatments on quality and glucosinolate content in broccoli (Brassica oleracea var. italica). Biol Technol. 2006, 41(Journal Article):1-8.
24. Rodriques AS, Rosa EaS: Effect of Postharvest treatment on the level of glucosinolates in broccoli. J Sci Food Agric. 1999, 79:1028-1032.
25. Song L, Thornalley PJ: Effect of storage, processing and cooking on glucosinolate content of Brassica vegetables. Food & Chemical Toxicology. 2007, 45(2):216-224.
26. Vallejo F, Tomã¡S-Barberã¡N FA, Garcã-a-Viguera C: Glucosinolates and vitamin C content in edible parts of broccoli florets after domestic cooking. European Food Research and Technology. 2007, 215(4):310-316.
27. Ministry of Health NZ, Government A. Nutrient Reference Values for Australia and New Zealand. Wellington; 2005: Report. Available from: www.nhmrc.gov.au/guidelines/publications/n35-n36-n37
28. Eastwood M, Kritchevsky D: Dietary fiber: how did we get where we are? Annu Rev Nutr. 2005, 25:1-8, Schneeman BO, Gallacher D: Effects of dietary fibre on digestive enzyme activity and bile acids in the small intestine. Proc Soc Exp Biol Med. 1985, 180(Journal Article):409-414.
29. Blaut M, Clavel T: Metabolic diversity of the intestinal microbiota: implications for health and disease. The Journal of nutrition. 2007, 137(3 Suppl 2):751S-755S.
30. Food and Nutrition Board. Dietary Reference Intakes. Washington D.C.: The National Academies Press; 2005.
31. Press WJG: Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World Journal of Gastroenterology. 2008, 14(42):6454.
32. Ccjm S, Schouten L, Weijenberg MP, Goldbohm RA, Van Den Brandt PA: Bowel Movement and Constipation Frequencies and the Risk of Colorectal Cancer Among Men in the Netherlands Cohort Study on Diet and Cancer. American Journal of Epidemiology. 2010, 172(Journal Article):1404-1414.
33. Park Y, Subar AF, Hollenbeck A, Schatzkin A: Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med. 2011, 171(12):1061-1068.
34. Howarth NC, Saltzman E, Roberts SB: Dietary fiber and weight regulation. Nutr Rev. 2001, 59(5):129-139.
35. Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J: Crohn's disease clinical course and severity in obese patients. Clinical nutrition (Edinburgh, Scotland). 2002, 21(1):51-57.
36. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR: Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. Journal of Crohn's & colitis. 2009, 3(1):8-14.
37. Hallberg L, Brune M, Rossander-Hulthen L: Is there a physiological role of vitamin C in iron absorption? Ann N Y Acad Sci. 1987, 498:324-332.
38. Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y: Criteria and Recommendations for Vitamin C Intake. JAMA: The Journal of the American Medical Association. 1999, 281(15):1415-1423.
39. Imes S, Dinwoodie A, Walker K, Pinchbeck B, Thomson AB: Vitamin C status in 137 outpatients with Crohn's disease. Effect of diet counseling. J Clin Gastroenterol. 1986, 8(4):443-446.
40. Rathbone BJ, Johnson AW, Wyatt JI, Kelleher J, Heatley RV, Losowsky MS: Ascorbic acid: a factor concentrated in human gastric juice. Clinical Science. 1989, 76:237-241.
41. Ng X, Lucock M, Veysey M: Physicochemical effect of pH and antioxidants on mono- and triglutamate forms of 5-methyltetrahydrofolate, and evaluation of vitamin stability in human gastric juice: Implications for folate bioavailability. Food Chemistry. 2008, 106(1):200-210.
42. Stein J, Bott C Diet and Nutrtion in Crohn's Disease and Ulcerative Colitis 20 questions 20 answers. In: wwwfalkfoundationorgnz. Freiburg: Falk Foundation; 2010.
43. Saxena A, Sharma RK: Nutritional aspect of nephrolithiasis. Indian J Urol. 2010, 26(4):523-530.
44. Viana ML, Pontes RM, Garcia WE, Favero ME, Prete DC, Matsuo T: Crohn's disease and kidney stones: much more than coincidence? Arq Gastroenterol. 2007, 44(3):210-214.
45. Drummond KE, Brefere LM. Nutrition for Foodservice and Culinary Professionals. Hoboken, New Jersey: John Wiley & Sons; 2004.
46. Chanarin I. The megaloblastic anaemias: Oxford Blackwell Scientific; 1979.
47. Hoffbrand A, Stewart J, Booth C, Mollin D: Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. British medical journal. 1968, 2(5597):71-75.
48. N H S. Anaemia, Vitamin B12 Or Folate Deficiency2012; Available from: www.nhs.uk/Conditions/Anaemia-vitamin-B12...folate.../Causes.aspx.
49. Steger GG, Mader RM, Vogelsang H, Schofl R, Lochs H, Ferenci P: Folate absorption in Crohn's disease. Digestion. 1994, 55(4):234-238.
50. De Bree A, Verschuren WMM, BjØrke-Monsen AL, Van Der Put NMJ, Heil SG, Trijbels FJM, Blom HJ: Effect of the methylenetetrahydrofolate reductase 677C ->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. The American Journal of Clinical Nutrition. 2003, 77(3):687-693.
51. Mahmud N, Molloy A, Mcpartlin J, Corbally R, Whitehead AS, Scott JM, Weir DG: Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut. 1999, 45(3):389-394.
52. N I H. Folates Fact Sheet: od.nih.gov; 2012. http://ods.od.nih.gov/factsheets/FolateHealthProfessional/
53. Pizzorno L. Vitamin A - Tolerance extends longevity2009; http://www.lmreview.com/articles/view/vitamin-a-tolerance-extends-longevity/(Journal,Electronic):September 2011-June 2009.
54. Ross A. Vitamin A. In: Shils ME, Shike M, Ross A, Caballero B, Cousins RJ, editors. In Modern Nutrition in Health and Disease. 10th Ed ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. pp. 351-375.
55. Stephensen CB: Vitamin A, infection, and immune function. Annu Rev Nutr. 2001, 21:167-192.
56. Wendland BE, Aghdassi E, Tam C, Carrrier J, Steinhart AH, Wolman SL, Baron D, Allard JP: Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. The American Journal of Clinical Nutrition. 2001, 74(2):259-264.
57. Grisham MB: Oxidants and free radicals in inflammatory bowel disease. The Lancet. 1994, 344(8926):859-861, Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet. 1994, 344(8924):721-724.
58. Mckenzie SJ, Baker MS, Buffinton GD, Doe WF: Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest. 1996, 98(1):136-141.
59. Leung WC, Hessel S, Meplan C, Flint J, Oberhauser V, Tourniaire F, Hesketh JE, Von Lintig J, Lietz G: Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J. 2009, 23(4):1041-1053.
60. Herbeth B, Gueguen S, Leroy P, Siest G, Visvikis-Siest S: The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study. J Am Coll Nutr. 2007, 26(6):655-662.
61. Penniston KL, Tanumihardjo SA: The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006, 83(2):191-201.
62. Suttie JW. Vitamin K. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease. Philadelphia: Lippincott Williams & Wilkins; 2006.
63. Booth SL, Webb DR, Peters JC: Assessment of phylloquinone and dihydrophylloquinone dietary intakes among a nationally representative sample of US consumers using 14-day food diaries. J Am Diet Assoc. 1999, 9:1072-1076.
64. Shearer MJ, Mcburney A, Barkhan P: Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm. 1974, 32:513-542.
65. O'reilly RA: Vitamin K and the Oral Anticoagulant Drugs. Annual Review of Medicine. 1976, 27(1):245-261.
66. Dignass A, Van Assche G, Lindsay JO, LeìMann M, SoìDerholm J, Colombel JF, Danese S, D'hoore A, Gassull M, Gomolloì•N F, Hommes DW, Michetti P, O'morain C, OìResland T, Windsor A, Stange EF, Travis SPL: The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Current management. Crohn's and Colitis. 2010, 4:28-62.
67. Han DY, Fraser AG, Dryland P, Ferguson LR: Environmental factors in the development of chronic inflammation: A case-control study on the risk factors for Crohn's disease in New Zealand. Mutation Research. 2010, 690:116-122.
68. Pettei MJ, Israel D, Levine J: Serum Vitamin K Concentration in Pediatric Patients Receiving Total Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition. 1993, 17(5):465-467.
69. Giangrande PL: Six characters in search of an author: the history of the nomenclature of coagulation factors. Br J Haematol. 2003, 121(5):703-712.
70. Booth SL, Tucker KL, Chen H, Hannan MT, Gagnon DR, Cupples LA, Wilson PW, Ordovas J, Schaefer EJ, Dawson-Hughes B, Kiel DP: Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr. 2000, 71(5):1201-1208.
71. Bernstein CN, Leslie WD, Leboff MS: AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology. 2003, 124(3):795-841.
72. Metheny NM. Fluid and electrolyte balance: nursing considerations: Sudbury, MA: Jones & Bartlett Learning; 2011. 69-90-69-90 p.
73. Jacobi J, Schnellhardt S, Opgenoorth M, Amann KU, Kuttner A, Schmid A, Eckardt KU, Hilgers KF: Severe metabolic alkalosis and recurrent acute on chronic kidney injury in a patient with Crohn's disease. BMC Nephrol. 2010, 11:6.
74. Adrogue HJ, Madias NE: Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007, 356(19):1966-1978.
75. Yu SP: Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol. 2003, 70(4):363-386.
76. Simms LA, Doecke JD, Roberts RL, Fowler EV, Zhao ZZ, Mcguckin MA, Huang N, Hayward NK, Webb PM, Whiteman DC, Cavanaugh JA, Mccallum R, Florin TH, Barclay ML, Gearry RB, Merriman TR, Montgomery GW, Radford-Smith GL: KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population. Am J Gastroenterol. 2010, 105(10):2209-2217.
77. American Cancer Society. Phytochemicals2011; http://www.cancer.org/Treatment/TreatmentsandSideEffects/ComplementaryandAlterna tiveMedicine(Journal, Electronic):October 2011.
78. Prior R. Phytochemicals. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease. Philadelphia: Lippincott Williams & Wilkins; 2006.
79. Fotsis T, Pepper MS, Montesano R, Aktas E, Breit S, Schweigerer L, Rasku S, Wahala K, Adlercreutz H: Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab. 1998, 12(4):649-666.
80. Mizoyama Y, Takaki H, Sugihara N, Furuno K: Inhibitory effect of flavonoids on Nacetylation of 5-aminosalicylic acid in cultured rat hepatocytes. Biol Pharm Bull. 2004, 27(9):1455-1458.
81. Pan MH, Lai CS, Dushenkov S, Ho CT: Modulation of inflammatory genes by natural dietary bioactive compounds. Journal of Agricultural & Food Chemistry. 2009, 57(11):4467-4477.
82. Kim JA, Kim DK, Kang OH, Choi YA, Park HJ, Choi SC, Kim TH, Yun KJ, Nah YH, Lee YM: Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells. Int Immunopharmacol. 2005, 5(1):209-217.
83. Walle T, Otake Y, Walle UK, Wilson FA: Quercetin glucosides are completely hydrolyzed in ileostomy patients before absorption. The Journal of nutrition. 2000, 130(11):2658-2661.
84. Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C: Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol. 1998, 275(1 Pt 2):R212-219.
85. Ruiz PA, Braune A, Holzlwimmer G, Quintanilla-Fend L, Haller D: Quercetin inhibits TNF-induced NF-kappaB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. The Journal of nutrition. 2007, 137(5):1208-1215.
86. Passamonti S, Vrhovsek U, Mattivi F: The interaction of anthocyanins with bilitranslocase. Biochem Biophys Res Commun. 2002, 296(3):631-636.
87. Wang H, Cao G, Prior RL: Oxygen radical absorbing capacity of anthocyanins. Journal of Agricultural & Food Chemistry. 1997, 45:304-309.
88. Nakaishi H, Matsumoto H, Tominaga S, Hirayama M: Effects of black current anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans. Altern Med Rev. 2000, 5(6):553-562.
89. Upton R. Bilberry Fruit Vaccinium myrtillus L. Standards of Analysis, Quality Control, and Therapeutics. American Herbal Pharmacopoeia and Therapeutic Compendium. Santa Cruz, CA2001.
90. Bagchi D, Sen CK, Bagchi M, Atalay M: Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc). 2004, 69(1):75-80.
91. Wu LH, Xu ZL, Dong D, He SA, Yu H: Protective Effect of Anthocyanins Extract from Blueberry on TNBS-Induced IBD Model of Mice. Evid Based Complement Alternat Med. 2011, 2011:525462.
92. Halkier BA, Gershenzon J: Biology and biochemistry of glucosinolates. Annual Review of Plant Biology. 2006, 57:303-333.
93. Mithen R, Faulkner K, Magrath R, Rose P, Williamson G, Marquez J: Development of isothiocyanate-enriched broccoli, and its enhanced ability to induce phase 2 detoxification enzymes in mammalian cells. Theoretical & Applied Genetics. 2003, 106(4):727-734.
94. Fahey JW, Zalcmann AT, Talalay P: The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry. 2001, 56(1):5-51.
95. Higdon JV, Delage B, Williams DE, Dashwood RH: Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacological Research. 2007, 55(3):224-236.
96. Bones AM, Rossiter JT: The enzymic and chemically induced decomposition of glucosinolates. Phytochemistry. 2006, 67(11):1053-1067.
97. Cheng DL, Hashimoto K, Uda Y: In vitro digestion of sinigrin and glucotropaeolin by single strains of Bifidobacterium and identification of the digestive products. Food & Chemical Toxicology. 2004, 42(3):351-357.
98. Ott SJ, Schreiber S: Reduced microbial diversity in inflammatory bowel diseases. Gut. 2004, 55:1207.
99. Frank DN, Robertson CE, Hamm CM: Disease phenotype and geno- type are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011, 17:179-184.
100. Dey M, Kuhn P, Ribnicky D, Premkumar V, Reuhl K, Raskin I: Dietary phenethylisothiocyanate attenuates bowel inflammation in mice. BMC Chemical Biology. 2010, 10:4.
101. Brauer HA, Libby TE, Mitchell BL, Li L, Chen C, Randolph TW, Yasui YY, Lampe JW, Lampe PD: Cruciferous vegetable supplementation in a controlled diet study alters the serum peptidome in a GSTM1-genotype dependent manner. Nutrition Journal. 2011, 10(11).
102. Steinbrecher A, Rohrmann S, Timofeeva M, Risch A, Jansen E, Linseisen J: Dietary glucosinolate intake, polymorphisms in selected biotransformation enzymes, and risk of prostate cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010, 19(1):135-143.
103. Peterson S, Schwarz Y, Li SS, Li L, King IB, Chen C, Eaton DL, Potter JD, Lampe JW: CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009, 18(11):3118-3125.
104. Campbell AK, Matthews SB, Vassel N, Cox CD, Naseem R, Chaichi J, Holland IB, Green J, Wann KT: Bacterial metabolic 'toxins': A new mechanism for lactose and food intolerance, and irritable bowel syndrome. Toxicology. 2010, 278(3):268-276.
105. FAO/WHO. Carbohydrates in Human Nutrition. Report of a Joint FAO/WHO Expert consultation.; 2011. Available from: www.who.int/entity/nutrition/publications/
106. Sarikami G, Balkaya A, Yanmaz R: Glucosinolates within a collection of white head cabbages (Brassica oleracea var. capitata sub.var. alba). African Journal of Biotechnology. 2009, 8(19):5046-5052.